$OTLKW Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Outlook Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Outlook Therapeutics, Inc.. Get notifications about new insider transactions in Outlook Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26 2017 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Buy | S | 1.13 | 26,165 | 29,566 | 54,820 | 28.7 K to 54.8 K (+91.31 %) |
| Dec 26 2017 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Buy | S | 1.13 | 15,705 | 17,747 | 50,899 | 35.2 K to 50.9 K (+44.62 %) |
| Dec 26 2017 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CFO and Secretary | Sell | S | 1.13 | 26,165 | 29,566 | 67,313 | 93.5 K to 67.3 K (-27.99 %) |
| Dec 20 2017 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | President & CEO | Sell | S | 1.14 | 83,608 | 95,313 | 7,171,230 | 7.3 M to 7.2 M (-1.15 %) |
| Dec 20 2017 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | President & CEO | Sell | S | 1.17 | 20,523 | 24,012 | 7,254,838 | 7.3 M to 7.3 M (-0.28 %) |
| Dec 20 2017 | ONS | Oncobiologics, Inc ... | Yamashita Elizabeth A. | VP, Regulatory Affa ... | Sell | S | 1.14 | 6,151 | 7,012 | 80,818 | 87 K to 80.8 K (-7.07 %) |
| Dec 20 2017 | ONS | Oncobiologics, Inc ... | Yamashita Elizabeth A. | VP, Regulatory Affa ... | Sell | S | 1.17 | 1,509 | 1,766 | 86,969 | 88.5 K to 87 K (-1.71 %) |
| Nov 02 2017 | ONS | Oncobiologics, Inc ... | Albrecht Claudio | Director | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
| Nov 02 2017 | ONS | Oncobiologics, Inc ... | Haddadin Yezan Munther | Director | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
| Nov 02 2017 | ONS | Oncobiologics, Inc ... | Sukhtian Faisal Ghiath | Director | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
| Nov 02 2017 | ONS | Oncobiologics, Inc ... | Thomas Joe | Director | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
| Nov 01 2017 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Chief Executive Off ... | Option Exercise | P | 0.90 | 16,750,000 | 15,075,000 | 16,750,000 | |
| Nov 01 2017 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Chief Executive Off ... | Option Exercise | P | 0.00 | 217,372 | 0 | 250,000 | |
| Oct 30 2017 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Option Exercise | A | 1.32 | 15,000 | 19,800 | 15,000 | |
| Oct 30 2017 | ONS | Oncobiologics, Inc ... | Brady Todd C | Director | Option Exercise | A | 1.32 | 15,000 | 19,800 | 15,000 | |
| Oct 30 2017 | ONS | Oncobiologics, Inc ... | Canute Scott A | Director | Option Exercise | A | 1.32 | 15,000 | 19,800 | 15,000 | |
| Oct 30 2017 | ONS | Oncobiologics, Inc ... | Dyrness Albert D. | Director | Option Exercise | A | 1.32 | 15,000 | 19,800 | 15,000 | |
| Jan 24 2017 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Option Exercise | X | 0.01 | 12,036 | 120 | 0 | |
| Jan 24 2017 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Buy | X | 0.01 | 12,036 | 120 | 30,554 | 18.5 K to 30.6 K (+65.00 %) |
| Dec 27 2016 | ONS | Oncobiologics, Inc ... | Dyrness Albert D. | Director | Option Exercise | P | 3.00 | 11,500 | 34,500 | 11,500 | |
| Dec 27 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Director | Option Exercise | P | 3.00 | 80,500 | 241,500 | 80,500 | |
| Dec 22 2016 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CFO and Secretary | Grant | A | 0.00 | 50,000 | 0 | 93,478 | 43.5 K to 93.5 K (+115.00 %) |
| Dec 22 2016 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Grant | A | 0.00 | 30,000 | 0 | 66,604 | 36.6 K to 66.6 K (+81.96 %) |
| Dec 22 2016 | ONS | Oncobiologics, Inc ... | Yamashita Elizabeth A. | VP, Regulatory Affa ... | Grant | A | 0.00 | 45,000 | 0 | 88,478 | 43.5 K to 88.5 K (+103.50 %) |
| Dec 22 2016 | ONS | Oncobiologics, Inc ... | Gangloff Scott A. | SVP, Development & ... | Grant | A | 0.00 | 40,000 | 0 | 118,573 | 78.6 K to 118.6 K (+50.91 %) |
| Dec 22 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 80,985 | 31 K to 81 K (+161.37 %) |
| Dec 22 2016 | ONS | Oncobiologics, Inc ... | Bao Kogan | VP, Analytical Scie ... | Grant | A | 0.00 | 50,000 | 0 | 71,739 | 21.7 K to 71.7 K (+230.00 %) |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | Smith Hoke Robin | Director | Option Exercise | J | 0.01 | 1,260 | 13 | 1,260 | |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | Smith Hoke Robin | Director | Buy | J | 0.00 | 1,939 | 0 | 1,939 | 0 to 1.9 K |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Option Exercise | J | 0.01 | 12,036 | 120 | 12,036 | |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Buy | J | 0.00 | 6,885 | 0 | 18,518 | 11.6 K to 18.5 K (+59.19 %) |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Buy | J | 0.00 | 11,633 | 0 | 11,633 | 0 to 11.6 K |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Director | Option Exercise | J | 0.01 | 37,315 | 373 | 37,315 | |
| Nov 30 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Director | Buy | J | 0.00 | 57,408 | 0 | 246,342 | 188.9 K to 246.3 K (+30.39 %) |
| Nov 28 2016 | ONS | Oncobiologics, Inc ... | Griffith Donald J. | Sell | S | 3.75 | 1 | 4 | 144,926 | 144.9 K to 144.9 K (0.00 %) | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Gangloff Scott A. | SVP, Development & ... | Sell | S | 3.75 | 37,369 | 140,134 | 78,573 | 115.9 K to 78.6 K (-32.23 %) |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Gangloff Scott A. | SVP, Development & ... | Buy | M | 0.00 | 115,942 | 0 | 115,942 | 0 to 115.9 K |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Gangloff Scott A. | SVP, Development & ... | Sell | C | 0.00 | 115,942 | 0 | 0 | 115.9 K to 0 (-100.00 %) |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Griffith Donald J. | Buy | M | 0.00 | 144,927 | 0 | 144,927 | 0 to 144.9 K | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Griffith Donald J. | Sell | C | 0.00 | 144,927 | 0 | 0 | 144.9 K to 0 (-100.00 %) | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Sell | S | 3.75 | 21,367 | 80,126 | 36,604 | 58 K to 36.6 K (-36.86 %) |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Buy | M | 0.00 | 57,971 | 0 | 57,971 | 0 to 58 K |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Sell | C | 0.00 | 57,971 | 0 | 0 | 58 K to 0 (-100.00 %) |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Buy | M | 0.00 | 57,971 | 0 | 188,934 | 131 K to 188.9 K (+44.27 %) | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Sell | C | 0.00 | 57,971 | 0 | 0 | 58 K to 0 (-100.00 %) | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Buy | M | 0.00 | 28,985 | 0 | 153,288 | 124.3 K to 153.3 K (+23.32 %) | |
| Nov 14 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Sell | C | 0.00 | 28,985 | 0 | 28,985 | 58 K to 29 K (-50.00 %) | |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | President & CEO | Option Exercise | C | 0.00 | 106 | 0 | 0 | |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | President & CEO | Buy | C | 0.00 | 17,666 | 0 | 39,405 | 21.7 K to 39.4 K (+81.26 %) |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Director | Option Exercise | C | 0.00 | 351 | 0 | 0 | |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Canute Scott A | Director | Buy | C | 0.00 | 58,500 | 0 | 130,963 | 72.5 K to 131 K (+80.73 %) |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Director | Option Exercise | C | 0.00 | 398 | 0 | 0 | |
| May 18 2016 | ONS | Oncobiologics, Inc ... | Brady Todd C | Director | Buy | C | 0.00 | 66,333 | 0 | 124,303 | 58 K to 124.3 K (+114.43 %) |
| May 17 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | P | 8.50 | 1,000 | 8,500 | 1,000 | |
| May 17 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | P | 6.60 | 1,000 | 6,600 | 1,000 | |
| May 17 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Buy | P | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |